The Bioreactors Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Bioreactors Market is estimated to be USD 1,019 million in 2016 and predicted to rise to USD 1,417 million by 2021 with a CAGR of 6.8%. The market is segmented by Material (Glass, Stainless-Steel, Single use), Scale (5L-20L, 20L-200L, 200L-1500L, Over 1500L), Production Size (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Control Type (Manual, Automated), End Users (R&D Departments, R&D Institutes, CRO’s, Biopharmaceutical Companies, Biopharmaceutical Manufacturers, CMO’s), and Suppliers (OEMs, System Integrators, EPCs). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
Rising chronic diseases prevalence, increase in incidence of lifestyle diseases like diabetes and cancer, rising biopharmaceutical investments, increasing demand for therapeutically active vaccines, product innovation and favourable governments initiatives to develop healthcare infrastructure are the factors driving the growth of market. Growing personalized medicine market and increasing popularity for them and increasing popularity of single-use bioreactor among the biopharmaceutical companies will also boost the market. Nevertheless, regulatory issues regarding single-use bioreactors, limited storage and vulnerability to leaching may hinder the growth of market. Likewise, large scale disposal of plastic derivatives is an environmental concern restraining the growth.
CMO’s are the major players in terms of end users. Single-use bioreactors are the most widely used one with 41 % share. Glass bioreactors are majorly used for R&D. Factors such as the increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies and growing biologics to drive the growth of the global bioreactors market.
North America is leading the market while Europe is at second place. Increasing financial support for development of innovative drugs and increase in no. of biopharmaceutical manufacturers has propelled the growth of these markets. Asia Pacific is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness and rapid medical and technological advancements in Asian countries like India and China.
Some of the key players dominating this market include Sartorius AG, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Danaher Corporation, Eppendorf AG, and major Engineering, Procurement and Construction (EPC) players included in this report are Amec Foster Wheeler plc., Fluor Corporation, Jacobs Engineering Group Inc., M+W Group, PM Group, and Technip S.A..
Browse through the full report at https://www.marketdataforecast.com/market-reports/bioreactors-market-2956/ and checkout our recent reports in the Medical Devices at https://www.marketdataforecast.com/subcategory/medical-devices-2/ For more insights and up-to-date industry news don’t forget subscribing to our newsletters.